Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy.

In people with type 2 diabetes, lower circulating levels of the vascular protective hormone Klotho are associated with increased risk of progression of diabetic retinopathy. Klotho may be a novel biomarker and potential treatment target for diabetic eye disease.